PHARMACYTE BIOTECH INC (PMCB) Stock Balance Sheet
USA - NASDAQ:PMCB - US71715X2036 - Common Stock
1.03 USD
-0.01 (-0.96%)
0.99 USD
-0.04 (-3.88%)
| MRQ (2025-7-31) | 2025 (2025-4-30) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 13.18M | 15.17M | 50.18M | 68.04M | 85.40M | |||
| Marketable Securities | 1.08M | 3.28M | N/A | N/A | N/A | |||
| Receivables | 4.61M | 3.70M | N/A | N/A | N/A | |||
| Other Current Assets | 238.20K | 223.80K | 259.80K | 110.00K | 90.00K | |||
| Total Current Assets | 19.11M | 22.38M | 50.44M | 68.15M | 85.49M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 22.60M | 28.18M | 0.00 | 1.57M | 1.57M | |||
| Intangibles | 1.55M | 1.55M | 1.55M | 3.55M | 3.55M | |||
| Other Non-Current Assets | 1.85M | 3.07M | 5.16M | 10.00K | 10.00K | |||
| Total Non-Current Assets | 26.00M | 32.79M | 9.46M | 5.13M | 5.13M | |||
| TOTAL ASSETS | 45.11M | 55.17M | 59.90M | 73.28M | 90.62M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 595.70K | 2.49M | 735.20K | 460.00K | 500.00K | |||
| Accounts Payable | 465.20K | 399.20K | 389.40K | 130.00K | 210.00K | |||
| Other Current Liabilities | 0.00 | 25.40K | 6.30M | N/A | N/A | |||
| Total Current Liabilities | 1.06M | 2.91M | 7.42M | 590.00K | 700.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 458.00K | 363.00K | 12.97M | N/A | N/A | |||
| Total Non-Current Liabilities | 458.00K | 363.00K | 12.97M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 1.52M | 3.28M | 20.39M | 590.00K | 700.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -93.33M | -84.97M | -115.63M | -115.96M | -111.65M | |||
| Additional Paid In Capital | 181.55M | 181.49M | 185.33M | 202.23M | 201.58M | |||
| Common Shares | 2.20K | 2.20K | 11.87M | 0.00 | 0.00 | |||
| Treasury Stock | -44.61M | -44.61M | -42.04M | -13.56M | N/A | |||
| Other Shareholders' Equity | -23.80K | -23.90K | -23.50K | -20.00K | -20.00K | |||
| Shares Outstanding | 6.80M | 6.80M | 8.04M | 16.79M | 20.72M | |||
| Tangible Book Value per Share | 6.19 | 7.41 | 3.25 | 4.12 | 4.17 | |||
| Total Shareholders' Equity | 43.59M | 51.89M | 39.51M | 72.69M | 89.92M | |||
| TOTAL LIABILITIES AND EQUITY | 45.11M | 55.17M | 59.90M | 73.28M | 90.62M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 18.01 | 7.68 | 6.80 | 115.51 | 122.13 | |||
| Return On Assets (ROA) | -7.80% | 42.35% | -28.78% | -5.90% | -4.68% | |||
| Return On Equity (ROE) | -8.07% | 45.02% | -43.62% | -5.94% | -4.72% | |||
All data in USD , ROIC based on taxRate of 0.21